Bios Therapeutics is a NEXT-GENERATION Rare Diseases Pharmaceutical organization providing services and solutions for geographical expansion of small and mid-size companies and acting on their behalf on local or regional level.
We aim for a Cultural shift from traditional expansion to a more flexible and tailor-made business model, following attractive tech-driven solutions for innovative treatments.
We provide significant financial benefits for partnering organizations and Easy-to-Adapt philosophy, driven by accomplished and passionate-for-success people, abiding to internal, local and international regulations and Good Pharmaceutical Practices.
Bios Therapeutics is a rare disease-oriented organization providing high quality services driven by ethics and transparency.
The Bios senior management and owners, pioneers in the Rare Diseases field, have more than two decades experience in various pharmaceutical organizations servicing EEC & Baltic regions as well as Greece, Cyprus & Malta.
Company Details
- Employees
- 5
- Address
- 146, Michalakopoulou Avenue, Athens,greece
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://biostherapeutics.com
- Keywords
- pharmaceuticals and rare disease.
- HQ
- Athens
Bios Therapeutics Questions
Bios Therapeutics's website is http://biostherapeutics.com
Bios Therapeutics's LinkedIn profile is https://gr.linkedin.com/company/bios-therapeutics
Bios Therapeutics has
5 employees.
View email and phone details for 5
employees at Bios Therapeutics.
Bios Therapeutics's industry is
Hospitals and Health Care
Bios Therapeutics's top competitors are
Adhd Hellas,
Randstad Greece,
Mevian,
Neucin,
Excessmed,
Resnova Srl,
Health2innovation,
Dutch Medical Food,
Orphan Europe,
Helcotex.
Bios Therapeutics's categories are Hospitals and Health Care
